Literature DB >> 26474468

Neighbourhood socio-economic status and all-cause mortality in adults with atrial fibrillation: A cohort study of patients treated in primary care in Sweden.

Per Wändell1, Axel C Carlsson2, Danijela Gasevic3, Jan Sundquist4, Kristina Sundquist4.   

Abstract

OBJECTIVE: Our aim was to study the potential impact of neighbourhood socio-economic status (SES) on all-cause mortality in patients with atrial fibrillation (AF) treated in primary care.
METHODS: Study population included adults (n=12,283) of 45 years and older diagnosed with AF in 75 primary care centres in Sweden. Association between neighbourhood SES and all-cause mortality was explored using Cox regression analysis, with hazard ratios (HRs) and 95% confidence intervals (95% CIs), and by Laplace regression where years to death (95% CI) of the first 10% of the participants were used as an outcome. All models were conducted in both men and women and adjusted for age, educational level, marital status, change of neighbourhood status, cardiovascular co-morbidities, anticoagulant treatment and statin treatment. High- and low-neighbourhood SES were compared with middle SES as reference group.
RESULTS: After adjustments for potential confounders, higher relative risk of all-cause mortality (HR 1.49, 95% CI 1.13-1.96) was observed in men living in low SES neighbourhoods compared to those from middle SES neighbourhoods. The results were confirmed using Laplace regression; the time until the first 10% of the men in low SES neighbourhoods died was 1.45 (95% CI 0.48-2.42) years shorter than for the men in middle SES neighbourhoods.
CONCLUSIONS: Increased rates of heart disease and subsequent mortality among adults in deprived neighbourhoods raise important clinical and public health concerns. These findings could serve as an aid to policy-makers when allocating resources in primary health care settings as well as to clinicians who encounter patients in deprived neighbourhoods.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Antithrombotic drugs; Atrial fibrillation; Co-morbidity; Follow-up; Gender; Mortality; Neighbourhood

Mesh:

Year:  2015        PMID: 26474468      PMCID: PMC4679195          DOI: 10.1016/j.ijcard.2015.09.027

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  51 in total

1.  Atrial fibrillation and mortality: the impact of antithrombotic therapy.

Authors:  Deirdre A Lane; Gregory Y H Lip
Journal:  Eur Heart J       Date:  2010-08-04       Impact factor: 29.983

2.  Self-rated health and allostatic load in women working in two occupational sectors.

Authors:  Dan Hasson; Ulrica Von Thiele Schwarz; Petra Lindfors
Journal:  J Health Psychol       Date:  2009-05

3.  Evaluating percentiles of survival.

Authors:  Nicola Orsini; Alicja Wolk; Matteo Bottai
Journal:  Epidemiology       Date:  2012-09       Impact factor: 4.822

4.  Coronary heart disease risks in first- and second-generation immigrants in Sweden: a follow-up study.

Authors:  K Sundquist; X Li
Journal:  J Intern Med       Date:  2006-04       Impact factor: 8.989

5.  Poor self-rated health is not associated with a high total allostatic load in type 2 diabetic patients--but high blood pressure is.

Authors:  A C Carlsson; A Nixon Andreasson; P E Wändell
Journal:  Diabetes Metab       Date:  2011-05-18       Impact factor: 6.041

6.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.

Authors:  W B Kannel; P A Wolf; E J Benjamin; D Levy
Journal:  Am J Cardiol       Date:  1998-10-16       Impact factor: 2.778

7.  Risks for stroke and bleeding with warfarin or aspirin treatment in patients with atrial fibrillation at different CHA(2)DS(2)VASc scores: experience from the Stockholm region.

Authors:  Tomas Forslund; Björn Wettermark; Per Wändell; Mia von Euler; Jan Hasselström; Paul Hjemdahl
Journal:  Eur J Clin Pharmacol       Date:  2014-09-16       Impact factor: 2.953

8.  Effects of prescribed antihypertensives and other cardiovascular drugs on mortality in patients with atrial fibrillation and hypertension: a cohort study from Sweden.

Authors:  Axel C Carlsson; Per Wändell; Kristina Sundquist; Sven-Erik Johansson; Jan Sundquist
Journal:  Hypertens Res       Date:  2014-03-06       Impact factor: 3.872

9.  Status syndrome: a challenge to medicine.

Authors:  Michael G Marmot
Journal:  JAMA       Date:  2006-03-15       Impact factor: 56.272

Review 10.  Heart failure and socioeconomic status: accumulating evidence of inequality.

Authors:  Nathaniel M Hawkins; Pardeep S Jhund; John J V McMurray; Simon Capewell
Journal:  Eur J Heart Fail       Date:  2012-02       Impact factor: 15.534

View more
  13 in total

1.  Depression or anxiety and all-cause mortality in adults with atrial fibrillation--A cohort study in Swedish primary care.

Authors:  Per Wändell; Axel C Carlsson; Danijela Gasevic; Lars Wahlström; Jan Sundquist; Kristina Sundquist
Journal:  Ann Med       Date:  2016-01-13       Impact factor: 4.709

2.  Neighborhood socioeconomic status at the age of 40 years and ischemic stroke before the age of 50 years: A nationwide cohort study from Sweden.

Authors:  Axel C Carlsson; Xinjun Li; Martin J Holzmann; Johan Ärnlöv; Per Wändell; Danijela Gasevic; Jan Sundquist; Kristina Sundquist
Journal:  Int J Stroke       Date:  2017-04-07       Impact factor: 5.266

3.  Association of Neighborhood Disadvantage and Anticoagulation for Patients with Atrial Fibrillation in the Veterans Health Administration: the REACH-AF Study.

Authors:  Annie McDermott; Nadejda Kim; Leslie R M Hausmann; Jared W Magnani; Chester B Good; Terrence M A Litam; Maria K Mor; Toluwa D Omole; Walid F Gellad; Michael J Fine; Utibe R Essien
Journal:  J Gen Intern Med       Date:  2022-09-23       Impact factor: 6.473

4.  Warfarin treatment and risk of myocardial infarction - A cohort study of patients with atrial fibrillation treated in primary health care.

Authors:  Per Wändell; Axel C Carlsson; Martin J Holzmann; Johan Ärnlöv; Sven-Erik Johansson; Jan Sundquist; Kristina Sundquist
Journal:  Int J Cardiol       Date:  2016-07-09       Impact factor: 4.164

5.  Socioeconomic factors and mortality in patients with atrial fibrillation-a cohort study in Swedish primary care.

Authors:  Per Wändell; Axel C Carlsson; Danijela Gasevic; Martin J Holzmann; Johan Ärnlöv; Jan Sundquist; Kristina Sundquist
Journal:  Eur J Public Health       Date:  2018-12-01       Impact factor: 3.367

6.  The usefulness of small-area-based socioeconomic characteristics in assessing the treatment outcomes of type 2 diabetes patients: a register-based mixed-effect study.

Authors:  Maija Toivakka; Aki Pihlapuro; Markku Tykkyläinen; Lauri Mehtätalo; Tiina Laatikainen
Journal:  BMC Public Health       Date:  2018-11-14       Impact factor: 3.295

7.  Metropolitan age-specific mortality trends at borough and neighborhood level: The case of Mexico City.

Authors:  Karol Baca-López; Cristóbal Fresno; Jesús Espinal-Enríquez; Miriam V Flores-Merino; Miguel A Camacho-López; Enrique Hernández-Lemus
Journal:  PLoS One       Date:  2021-01-19       Impact factor: 3.240

Review 8.  Social determinants of atrial fibrillation.

Authors:  Utibe R Essien; Jelena Kornej; Amber E Johnson; Lucy B Schulson; Emelia J Benjamin; Jared W Magnani
Journal:  Nat Rev Cardiol       Date:  2021-06-02       Impact factor: 32.419

9.  Comparison of individual and neighbourhood socioeconomic status in case mix adjustment of hospital performance in primary total hip replacement in Sweden: a register-based study.

Authors:  Johan Mesterton; Carl Willers; Tobias Dahlström; Ola Rolfson
Journal:  BMC Health Serv Res       Date:  2020-07-10       Impact factor: 2.655

Review 10.  Psychological aspects of atrial fibrillation: A systematic narrative review : Impact on incidence, cognition, prognosis, and symptom perception.

Authors:  Karl-Heinz Ladwig; Andreas Goette; Seryan Atasoy; Hamimatunnisa Johar
Journal:  Curr Cardiol Rep       Date:  2020-09-10       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.